Experimental drug may slow childhood brain tumors
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
Jan 23, 2024
0
64
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
Jan 23, 2024
0
64
Doctors in Missouri recently made a startling discovery. A 63-year-old patient who went for a routine colon screening was found to have an intact fly in his colon. The doctors had no idea how the fly survived the perilous ...
Nov 24, 2023
0
0
Surgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international team led by Patrick Starlinger from MedUni Vienna has developed a score that provides an ...
Nov 2, 2023
0
0
Surgery of the thyroid and parathyroid glands is most challenging, even to expert surgeons. These relatively small structures located in the neck are in contact with each other and share certain features, including color ...
Aug 29, 2023
0
16
Chronic inflammation of the middle ear can cause several problems and complications that can affect a person's hearing and balance. One such problem is the formation of a cholesteatoma, which is an abnormal collection of ...
Aug 3, 2023
0
18
An emulated randomized trial performed using observational data from more than 43,000 adults with primary hyperparathyroidism found that parathyroidectomy had no estimated effect on long-term kidney function in older adults ...
Apr 10, 2023
0
7
Bile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.
Feb 1, 2023
0
2
Among individuals treated at a gender identity clinic in The Netherlands, those who used puberty suppressing treatment before the age of 18 and then started gender-affirming hormones, 98% (704 out of 720) continued use at ...
Oct 21, 2022
0
23
An experimental drug being trialed for advanced solid tumors, including the most aggressive brain cancer—glioblastoma—has passed the first phase with flying colors, raising hopes for an effective new treatment.
Sep 23, 2022
0
5
Scientists have shown how tumor cells evade immunotherapy by generating unique, temporary cell-in-cell structures, where the inner cells remain in tact and can return to single tumor cells.
Sep 20, 2022
0
15